KETAMINE HYDROCHLORIDE
Generic: KETAMINE HYDROCHLORIDE
Baxter Healthcare CorporationManufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
KETAMINE HYDROCHLORIDEActive Substance
2025-09-17Original Approval
KETAMINE HYDROCHLORIDE is FDA application ANDA219684, sponsored by BAXTER HLTHCARE CORP. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
INFUSION SITE PAIN
733 reports
2
DRUG INEFFECTIVE
490 reports
3
NAUSEA
476 reports
4
INFUSION SITE ERYTHEMA
462 reports
5
OFF LABEL USE
398 reports
6
INFUSION SITE SWELLING
313 reports
7
HEADACHE
312 reports
8
DIARRHOEA
291 reports
9
DYSPNOEA
279 reports
10
HYPERHIDROSIS
215 reports